Author(s):
Manish Kumar Sahu, Dolly Dewangan, Jitendra Yadav, Kamraj, Krity Gupta, Parimal Verma, Prashant Kumar Sahu, Shweta Sinha, Adeep Kujur, S. J. Daharwal
Email(s):
Email ID Not Available
DOI:
10.52711/2231-5691.2026.00014 
Address:
Manish Kumar Sahu*, Dolly Dewangan, Jitendra Yadav, Kamraj, Krity Gupta, Parimal Verma, Prashant Kumar Sahu, Shweta Sinha, Adeep Kujur, S. J. Daharwal
University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur (C.G).
*Corresponding Author
Published In:
Volume - 16,
Issue - 1,
Year - 2026
ABSTRACT:
A simple analytical Method is developed for identification and quantification of related impurities in the API and pharmaceutical dosage form. Rifapentine is an antibiotic from the rifamycin class that is utilized in the treatment of tuberculosis. The solvent, method, analytical procedure, reaction time, Solvent concentration used are carefully optimized with Maximum sensitivity. The developed method is Validated as per the guidelines of International Conference Harmonization (ICH.) the proposed method is precise and accurate and for the routine analysis of Rifapentine hence can be used for bulk and pharmaceutical dosage form.
Cite this article:
Manish Kumar Sahu, Dolly Dewangan, Jitendra Yadav, Kamraj, Krity Gupta, Parimal Verma, Prashant Kumar Sahu, Shweta Sinha, Adeep Kujur, S. J. Daharwal. A Review on Development and validation of analytical method for estimation of Rifapentine in bulk and Pharmaceutical formulation. Asian Journal of Pharmaceutical Research. 2026; 16(1):101-5. doi: 10.52711/2231-5691.2026.00014
Cite(Electronic):
Manish Kumar Sahu, Dolly Dewangan, Jitendra Yadav, Kamraj, Krity Gupta, Parimal Verma, Prashant Kumar Sahu, Shweta Sinha, Adeep Kujur, S. J. Daharwal. A Review on Development and validation of analytical method for estimation of Rifapentine in bulk and Pharmaceutical formulation. Asian Journal of Pharmaceutical Research. 2026; 16(1):101-5. doi: 10.52711/2231-5691.2026.00014 Available on: https://asianjpr.com/AbstractView.aspx?PID=2026-16-1-14
REFERENCE:
1. Tahir, A., Kalkotwar, R. S., Naikwade, J., and Shaikh, A. Development and validation of UV/Visible spectrophotometric method for the estimation of Rifapentine in bulk and pharmaceutical formulations. American Journal of Phytomedicine and Clinical Therapeutics. 2013; 1: 401-407.
2. Jain, P., and Pathak, V. M. Development and validation of UV-visible spectrophotometric method for estimation of rifapentine in bulk and dosage form. Der Phara Chemica. 2013; 5: 251-255.
3. Amol, C. D., and Prasad, P. D. Quantitative estimation of rifapentine using UV-spectrophotometry-Area under curve technique in bulk and tablets.
4. Benator D, Bhattacharya M, Bozeman L, BurmanW, Cantazaro A et al. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. The Lancet. 2002; 360: 528-534.]
5. Data submitted to Department of Health and Human Services for NDAapproval. Pritin (rifapentine). Kansas City, MO: Hoechst Marion Rous-sel Inc., 1998.
6. Mitchison, D. A. Basic Mechanisms of Chemotherapy. Chest. 1979; 76(6): 771-780.
7. Ravisankar, P., Gowthami, S., and Rao, G. D. A review on analytical method development. Indian Journal of Research in Pharmacy and Biotechnology. 2014; 2(3): 1183.
8. Mandru, A., Mane, J., and Mandapati, R. A Review on UV-visible spectroscopy. Journal of Pharma Insights and Research. 2023; 1(2): 091-096.
9. Atole, D. M., and Rajput, H. H. Ultraviolet spectroscopy and its pharmaceutical applications-a brief review. Asian J Pharm Clin Res. 2018; 11(2): 59-66.
10. Kumar, A., Jawla, S., and Yadav, G. Recent analytical method developed by RP-HPLC. Global Journal of Pharmacology. 2013; 7(3): 232-240.
11. Tahir, A., Kalkotwar, R. S., Sachin, P., Haseeb, M., and Asghar, J. Development and validation of Rp-Hplc method for the estimation of Rifapentine in bulk and pharmaceutical formulation. Am J Adv Drug Deliv. 2014; 1(2): 76-84.
12. Bethi, M. R., and Bethanamudi, P. (). Analytical Method Development and Validation of Impurity Profile in Rifapentine. International Journal of Theoretical and Applied Sciences. 2017; 9(2): 99-105.
13. Singh, H. P. Development and validation of QbD approach in RP-HPLC analytical method for separation and identification of anti-tuberculosis drug Rifapentine. Frontiers in Health Informatics. 2024;13(8).
14. A., Jadhav, S., Patil, D., Pathade, P., Deore, R., and Ahire, Y. Development And Validation Of Rp-Hplc Method For Determination Of Rifapentine And Moxifloxacin Hydrochloride In Bulk And Tablet Dosage Form. Journal of Pharmaceutical Negative Results. 2022; 13.
15. Jain, A., Parashar, A. K., Nema, R. K., and Narsinghani, T. High performance thin layer chromatography (HPTLC): A modern analytical tool for chemical analysis. Current Research in Pharmaceutical Sciences. 2014; 8-14.
16. Ghantiwala, N. B., Dedania, Z., Dedania, R., and Patel, U. Development and validation of stability indicating high‐performance thin‐layer chromatographic method for estimation of Rifapentine in pharmaceutical formulation. Separation Science Plus. 2024; 7(2): 2300130.
17. Mkhize, B., Kellermann, T., Norman, J., Castel, S., Joubert, A., van der Merwe, M., ... and Wiesner, L. Validation and application of a quantitative liquid chromatography tandem mass spectrometry assay for the analysis of rifapentine and 25-O-desacetyl rifapentine in human milk. Journal of Pharmaceutical and Biomedical Analysis. 2022; 215: 114774.
18. Parghale, R., Inapakolla, R., Tikka, V. D. R., Suvvaru, R. K., Gawade, V., Anil, A., and Jagdale, S. Bioanalytical method validation of rifapentine and its metabolite in human plasma using the LC-MS/MS method, as well as its application to a pharmacokinetics study. J Appl Pharm Sci. 2025; 15(4): 179-201.
19. Parsons, T. L., Marzinke, M. A., Hoang, T., Bliven-Sizemore, E., Weiner, M., Mac Kenzie, W. R., and Dooley, K. E. Quantification of rifapentine, a potent antituberculosis drug, from dried blood spot samples using liquid chromatographic-tandem mass spectrometric analysis. Antimicrobial Agents and Chemotherapy. 2014; 58(11): 6747-6757